DEUTSCHE BANK AG\
BankPosition in BMRN — Biomarin Pharmaceutical Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in BMRN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,226,081
-$16,008,366 QoQ
Shares Held
126,286
-69.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#131
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. BMRN ranks #50 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,226,081 | 126,286 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $23,234,447 | 411,302 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $40,867,511 | 687,658 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $58,816,835 | 1,085,983 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $48,814,951 | 888,029 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $133,416,979 | 1,887,353 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $109,737,415 | 1,669,518 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $108,680,077 | 1,546,167 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $148,772,941 | 1,807,032 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $204,308,869 | 2,339,236 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $328,039,829 | 3,402,197 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $123,758,653 | 1,398,719 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $172,927,114 | 1,995,006 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $203,890,398 | 2,096,775 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $247,213,390 | 2,388,766 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $187,644,663 | 2,213,574 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $101,646,512 | 1,226,578 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $68,710,049 | 891,181 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $83,145,737 | 941,095 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $69,010,612 | 892,879 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $98,199,779 | 1,176,891 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $85,937,246 | 1,138,091 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $92,808,898 | 1,058,375 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $104,499,524 | 1,373,548 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $184,030,181 | 1,492,056 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $125,339,944 | 1,483,313 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||